BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2817829)

  • 1. Striatal dopamine deficiency in Parkinson's disease: role of aging.
    Scherman D; Desnos C; Darchen F; Pollak P; Javoy-Agid F; Agid Y
    Ann Neurol; 1989 Oct; 26(4):551-7. PubMed ID: 2817829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
    Kish SJ; Shannak K; Hornykiewicz O
    N Engl J Med; 1988 Apr; 318(14):876-80. PubMed ID: 3352672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein in Lewy bodies.
    Spillantini MG; Schmidt ML; Lee VM; Trojanowski JQ; Jakes R; Goedert M
    Nature; 1997 Aug; 388(6645):839-40. PubMed ID: 9278044
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-κB signaling pathways in peripheral monocytic cells.
    Bearoff F; Dhavale D; Kotzbauer P; Kortagere S
    Mol Immunol; 2023 Feb; 154():1-10. PubMed ID: 36571978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A
    Nunes ACL; Carmo M; Behrenswerth A; Canas PM; Agostinho P; Cunha RA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using
    Beauchamp LC; Dore V; Villemagne VL; Xu S; Finkelstein D; Barnham KJ; Rowe C
    Neurology; 2023 Nov; 101(22):e2314-e2324. PubMed ID: 37816639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram.
    Karabayir I; Gunturkun F; Butler L; Goldman SM; Kamaleswaran R; Davis RL; Colletta K; Chinthala L; Jefferies JL; Bobay K; Ross GW; Petrovitch H; Masaki K; Tanner CM; Akbilgic O
    Sci Rep; 2023 Jul; 13(1):12290. PubMed ID: 37516770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, Dopaminergic Brain and Bilirubin.
    Jayanti S; Dalla Verde C; Tiribelli C; Gazzin S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson.
    Pifl C; Reither H; Attems J; Zecca L
    NPJ Parkinsons Dis; 2023 Jun; 9(1):89. PubMed ID: 37322038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology of incidental Lewy body & prodromal Parkinson's disease.
    Koeglsperger T; Rumpf SL; Schließer P; Struebing FL; Brendel M; Levin J; Trenkwalder C; Höglinger GU; Herms J
    Mol Neurodegener; 2023 May; 18(1):32. PubMed ID: 37173733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson's Disease.
    Kolacheva A; Bannikova A; Pavlova E; Bogdanov V; Ugrumov M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review.
    Zhang TD; Kolbe SC; Beauchamp LC; Woodbridge EK; Finkelstein DI; Burrows EL
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.
    Pang SY; Lo RCN; Ho PW; Liu HF; Chang EES; Leung CT; Malki Y; Choi ZY; Wong WY; Kung MH; Ramsden DB; Ho SL
    Transl Neurodegener; 2022 Jan; 11(1):5. PubMed ID: 35101134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VMAT2 availability in Parkinson's disease with probable REM sleep behaviour disorder.
    Valli M; Cho SS; Uribe C; Masellis M; Chen R; Mihaescu A; Strafella AP
    Mol Brain; 2021 Nov; 14(1):165. PubMed ID: 34758845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease: removing axonal debris.
    Morales I; Puertas-Avendaño R; Sanchez A; Perez-Barreto A; Rodriguez-Sabate C; Rodriguez M
    Transl Neurodegener; 2021 Nov; 10(1):43. PubMed ID: 34727977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared Genetic Background between Parkinson's Disease and Schizophrenia: A Two-Sample Mendelian Randomization Study.
    Kim K; Kim S; Myung W; Shim I; Lee H; Kim B; Cho SK; Yoon J; Kim DK; Won HH
    Brain Sci; 2021 Aug; 11(8):. PubMed ID: 34439661
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB.
    Chou TW; Chang NP; Krishnagiri M; Patel AP; Lindman M; Angel JP; Kung PL; Atkins C; Daniels BP
    Cell Death Dis; 2021 Jul; 12(8):756. PubMed ID: 34333522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
    Gundersen V
    Front Neurosci; 2020; 14():580311. PubMed ID: 33716638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT.
    Schmitz-Steinkrüger H; Lange C; Apostolova I; Mathies FL; Frings L; Klutmann S; Hellwig S; Meyer PT; Buchert R
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1445-1459. PubMed ID: 33130960
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.